Tsc1 haploinsufficiency in Nkx2.1 cells upregulates hippocampal interneuron mTORC1 activity, impairs pyramidal cell synaptic inhibition, and alters contextual fear discrimination and spatial working memory in mice.

This is a mouse model study; results may not translate to human physiology or behavior. Sample sizes for some electrophysiology groups were small. The use of viral vectors for optogenetics introduced variability in protein expression. Rapamycin treatment was tested only on synaptic function, not directly on the behavioral deficits observed.

Funded by the Canadian Institutes of Health Research and Canada Research Chairs. No commercial conflicts of interest were reported.

Do not interpret this as evidence that rapamycin improves memory in patients with tuberous sclerosis or autism. The study only shows that the drug corrected a specific cellular signal in mouse brain slices, and it did not test whether the drug fixed the memory problems in the living animals.